CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Dnyanada Kulkarni
/ Categories: Trending, DSIJ News

Overnight Digest: Stocks to watch on December 24

The stocks most likely to witness significant movement on the bourses on December 24 are Unichem Laboratories, CMI, Info Edge (India), Sun Pharma and PVR.

Unichem Laboratories: The company received final ANDA approval for its Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg from the USFDA for the treatment of Parkinson’s disease and moderate-to-severe primary Restless Leg Syndrome (RLS). The stock will be monitored on Monday.

CMI: The company got production clearance for BHEL export order worth Rs. 79 crore for its overseas project to supply LT XLPE and HT XPLE cables to be executed in the next 4 months. The stock is likely to witness movement in Monday’s trading session.

Info Edge (India): The company, through its wholly-owned subsidiary, invested Rs. 28 crore in Nopaperforms Solutions Pvt. Ltd. The stock will be watched on Monday.

Sun Pharma: One of the company’s subsidiaries received approval from the US health regulator to market Elepsia XR, an antiepileptic drug. The stock will be watched on Monday.

PVR: The company's board approved the issue of equity shares of face value Rs. 10 each or securities convertible into equity shares, or non-convertible debt instruments along with warrants, or any combination thereof in one or more tranches, to eligible qualified institutional buyers for an aggregate amount of up to Rs. 750 crore. The stock will be monitored on Monday.

Previous Article Ten stocks close to their 52-week low
Next Article Texmaco Rail bags order for 1,621 wagons
Print
2075 Rate this article:
4.9
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR